2020 POSTERS
#100 - Calcipotriene Foam Pediatric Safety and Tolerability Study

Adelaide Hebert MD, Debbie Glaab MSN, Rhonda Schreiber MSRN
#101 - Real World Patient Perceptions of the Use of Calcipotriene Foam 0.005% in the Treatment of Plaque Psoriasis

Francisco Kerdel MD, Christina Don PA, Renata Block PA, Caitlin Lewis PhD, Rhonda Schreiber MSRN
#102 - Real World Patient Perceptions of the Use of Tazarotene 0.1% Foam in the Treatment of Acne Vulgaris Update

James DelRosso DO, Corey Hartman MD, Caitlin Lewis PhD, Rhonda Schreiber MSRN
#103 - Ixekizumab Demonstrates Sustained High Efficacy and Consistent Safety in Patients with Moderate-to-Severe Psoriasis: 5 Years of Follow-up from UNCOVER-3

Andrew Blauvelt, Tomotaka Mabuchi, Ann Leung, Alyssa Garrelts, Heidi Crane, Hany ElMaraghy, Himanshu Patel, Terri Ridenour, Gaia Gallo, Mark G Lebwohl
#104 - Comparison of Ixekizumab and Guselkumab in the Treatment of Nail Psoriasis in Patients with Moderate-to-Severe Plaque Psoriasis: 24-week Results from a Randomized, Double-Blind, Head-to-Head Study (IXORA-R)

Lyn Guenther, Hany Elmaraghy, Gaia Gallo, Lisa Renda, So Young Park, Jeffrey Crowley
#105 - Ixekizumab vs. Guselkumab: Direct Comparison of Cumulative Clinical and Quality of Life Benefits Over 24 Weeks of Treatment in Patients with Moderate-to-Severe Plaque Psoriasis

Andrew Blauvelt, Kim A. Papp, Melinda Gooderham, Kenneth B. Gordon, Neil J. Korman, Ronald Vender, Russel Burge, Baojin Zhu, Gaia Gallo, So Young Park, Hany Elmaraghy, Fangyu Wang, Renata Gontijo Lima, Lisa Renda
#106 - Outcomes in Ixekizumab Initiators by Prior Biologic Status in the Corrona® Psoriasis Registry

Abby S. Van Voorhees, Ryan W. Harrison, Russel Burge, William N. Malatestinic, Baojin Zhu, Bilal Atiya, Mwangi J. Murage, Robert R. McLean, Margaux Crabtree, Jacqueline O’Brien, Benjamin Lockshin
#107 - Dupilumab Provides Clinically Meaningful Responses Versus Placebo: A Post Hoc Analysis of a Phase 3 Trial in Adolescents with Moderate-to-Severe AD among Patients not Achieving IGA score of 0/1

Eric L. Simpson, Ashish Bansal, Mark Boguniewicz, Andrew Blauvelt, Emma Guttman-Yassky, Zhen Chen, Ana B. Rossi, Abhijit Gadkari
#108 - The Patient-Reported Disease Burden in Pediatric Patients with Atopic Dermatitis (AD): A Cross-Sectional Study in the United States (US), Canada, Europe and Japan

Stephan Weidinger, Eric L Simpson, Laurent Eckert, Jonathan I Silverberg, Sebastien Barbarot, Paola Mina-Osorio, Ana Rossi, Isabelle Guillemin, Marine Pellan, Abhijit Gadkari
#109 - An Oral, Selective TYK2 Inhibitor, BMS-986165, in Patients With Moderate-to-Severe Plaque Psoriasis and Baseline PASI ≤15 Versus >15

Peter Foley, Melinda Gooderham, Kenneth Gordon, Diamant Thaçi, Sudeep Kundu, Renata Kisa, Lan Wei, Subhashis Banerjee
#110 - BMS-986165, an Oral, Selective Tyrosine Kinase 2 Inhibitor: Evaluation of Changes in Laboratory Parameters in Response to Treatment in a Phase 2 Trial in Psoriasis Patients

Kenneth Gordon, Kim Papp, Melinda Gooderham, Akimichi Morita, Peter Foley, Diamant Thaçi, Sudeep Kundu, Renata Kisa, Lan Wei, Subhashis Banerjee
#111 - 1 Efficacy and Safety of Bimekizumab in Patients with Moderate to Severe Plaque Psoriasis: Results from BE READY, a 56-Week Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study with Randomized Withdrawal

Kenneth Gordon, Peter Foley, James Krueger, Andreas Pinter, Kristian Reich, Ronald Vender, Veerle Vanvoorden, Cynthia Madden, Luke Peterson, Andrew Blauvelt
#112 - Efficacy and Safety of Bimekizumab in Patients with Moderate to Severe Plaque Psoriasis: Results from BE VIVID, a 52-Week Phase 3, Randomized, Double-Blinded, Ustekinumab- and Placebo-Controlled Study

Kristian Reich, Kim A. Papp, Andrew Blauvelt, Richard Langley, April Armstrong, Richard B. Warren, Kenneth Gordon, Joseph F. Merola, Cynthia Madden, Maggie Wang, Veerle Vanvoorden, Mark Lebwohl
#113 - Durable Efficacy of Certolizumab Pegol Dosed at 400 mg Every Two Weeks Over 128 Weeks in Patients with Plaque Psoriasis Enrolled in Three Phase 3 Trials (CIMPASI-1, CIMPASI-2 and CIMPACT)

Kenneth Gordon, Richard B. Warren, Alice B. Gottlieb, Andrew Blauvelt, Diamant Thaçi, Yves Poulin, Marion Boehnlein, Fiona Brock, Catherine Arendt, Kristian Reich
#114 - Reductions in Absolute PASI Over 144 Weeks of Treatment with Certolizumab Pegol in Patients with Plaque Psoriasis: Pooled Analysis from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)

Alice B. Gottlieb, Andrew Blauvelt, Diamant Thaçi, Yves Poulin, Fiona Brock, Catherine Arendt, Marion Boehnlein, Kristian Reich
#115 - Efficacy of Tapinarof Cream by Body Region in Subjects with Plaque Psoriasis in a Phase 2b Randomized Controlled Study

Robert Bissonnette, Linda Stein Gold, Leon Kircik, Stephen Tyring, Anna Tallman, April Armstrong
#116 - Tapinarof Cream for the Treatment of Plaque Psoriasis: Efficacy and Safety by Baseline Disease Characteristics and Skin Type in a Phase 2b Randomized Study

Mark Lebwohl, James Del Rosso, Chih-ho Hong, Anna Tallman, Leon Kircik
#117 - Oral Sarecycline for Moderate to Severe Acne Vulgaris

Angela Moore1, Lawrence Green2, Suzanne Bruce3 et al.*
#118 - Tirbanibulin Ointment 1% for Actinic Keratosis (AK): Results From Two Phase 3 Studies with 1-Year Follow-up

Andrew Blauvelt, Steven Kempers, Susana Puig, George Martin, Emilio Fumero, Ayman Grada, David Cutler, Jane Fang 
#119 - A Multi-Center, Open-Label Extension Study to Assess the Long-term Safety/Tolerability and Pharmacokinetics, and Explore the Efficacy of Sofpironium Bromide Gel, 15% Applied Topically to Children and Adolescents, 9 to 16 Years of Age, with Primary Axillar

Brandon Kirsch, MD, Janet DuBois, MD, Martin N. Zaiac, MD, Sanjeev Ahuja, MD, MBA, FACP, Deepak Chadha, MS, MBA, RAC
#120 - Efficacy and Safety of Long-Term Tildrakizumab for Plaque Psoriasis: 4-Year Results from reSURFACE 1 and reSURFACE 2

Richard G Langley, Jeffrey Crowley, Melinda Gooderham, Kim A Papp, Neil J Korman, Lynda Spelman, Atsuyuki Igarashi, Mamitaro Ohtsuki, Aditya K Gupta, Paul Yamauchi, Alan M Mendelsohn, Stephen J Rozzo, Kimberly Eads, Scott Guenthner, M Alan Menter
#121 - Tildrakizumab Efficacy by Metabolic Syndrome Status in Psoriasis: Post Hoc Analysis of 3-Year Data from the Phase 3 reSURFACE 1 and reSURFACE 2 Studies

Mark G Lebwohl, Nehal N Mehta, Alice B Gottlieb, Alan M Mendelsohn, Stephen J Rozzo, M Alan Menter
#122 - Efficacy and safety of tildrakizumab, a high-affinity anti–interleukin-23p19 monoclonal antibody, in patients with active psoriatic arthritis 

Philip J Mease, Saima Chohan, Ferran J García Fructuoso, Alice B Gottlieb, Proton Rahman, Siba P Raychaudhuri, Richard C Chou, Alan M Mendelsohn, Stephen J Rozzo, Cynthia Trickett, Melodie Young, Michael E Luggen
#123 - Folliculocystic and Collagen Hamartoma in Tuberous Sclerosis Complex: A Case Report

Kyle F Norton, BA; Anita S Savell, BS; Michael R Heaphy, Jr., MD
#124 - Acrokeratosis paraneoplastica (Bazex syndrome) as the Presenting Sign of Pancreatic Adenocarcinoma

Luke Horton, Lisa Bedford, Steven Daveluy​
#125 - An Eruption of Numerous Spiny Papules in a Pediatric Transplant Patient

​Luke Horton, BA; Fatima Fahs, MD; Amrish Jain, MD; Geoffrey Potts, MD
#126 - An Atypical Presentation of a Primary Dermal Leiomyosarcoma 

Robert Daze DO, Krina Chavda DO, Richard Miller DO
#127 - Psychological Safety and Wellbeing of Dermatology Residents during the COVID-19 Pandemic 

Yong Lee BS, Andrea Murina MD
#128 - A Case of Macular Lymphocytic Arteritis in a Caucasian Male

Thao Pham, BS; Scott Mahlberg, DO; Gloria Stevens, MD; Gene Kim, MD; Angel Delores, BS; Alec Ziemann, BS
#129 - West Coast Ticks, They Do Bite

Thao Pham, BS; Alec Ziemann, BS; Melanie Kuechle MD
#130 - Retrospective Study of Factors Affecting Compliance in Patients Who Were Prescribed Efinaconazole 10% Solution for Onychomycosis

Albert G. Wu, MS; Solomon Geizhals, BA, Shari R. Lipner, MD PhD
#131 - Cutaneous Invasive Ductal Carcinoma Masquerading as Pseudoxanthoma Elasticum

Christina Borchers, MD, Hershel Dobkin, MD, Zachary Ingersoll, DO, Marc Handler, MD
#132 - Clinical and Diagnostic Imaging Manifestations of Erdheim-Chester Disease

Christina Borchers, MD, Roland Gazaille, DO, Avrey Thau, MD, Alejandro Calvo, MD, Ronald Warwar, MD, William Boyce, MD, Joseph Blake, MD
#133 - Accidental Silver Clay Tattoo: Mystery Finding in a Jewelry Smith

Christina Borchers, MD, Tom Selby, MD, Samia Borchers, MD
#134 - Periungual Papules in an Elderly Woman

Stacy Kasitinon; Jennifer Day; Travis Vandergriff; Jennifer Gill
#135 - Human Botfly Infestation: Furuncular Myiasis

Rachel Rhee, BA, Christina Borchers, MD, Samia Borchers, MD
#136 - In the Era of Social Media and Medicine: Evaluating YouTube As a Source of Information on Rosacea

Sandra Oska, Andrina Mamo
#137 - The Impact of Varied Educational Models on Student Learning: Utilizing Simulation in Dermatology

Laurie A. Temiz BA, Sharon E. Albers MD, Chau-Kuang Chen EdD, Tiffany Turner PhD, Regina Offodile MD
#138 - Study Using a 21-Day Wound Care System

Eric A. Lewis MD
#139 - Peak Pruritus Numeric Rating Scale (PP-NRS) Response With Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis (AD): Results From a Randomized, Phase 3 Clinical Trial

Eric L. Simpson, Sonja Ständer, Gil Yosipovitch, Brian Kim, Michael Cameron, Marco DiBonaventura, David Williams, Svitlana Tatulych, Chudy Nduaka, Hernan Valdez
#140 - Prevalence and Impact of Psychosocial Comorbidities on Health Status Among Patients With Moderate-to-Severe Atopic Dermatitis (AD) in the United States: Analysis of the 2017 US National Health and Wellness Survey (NHWS)

Shawn G. Kwatra, Mamta B. Jhaveri, David Gruben, Selwyn Fung, Marco DiBonaventura
#141 - Health Status, Work Productivity, and Healthcare Resource Utilization (HCRU) in Patients With Moderate-to-Severe Atopic Dermatitis (AD): Analysis of the 2017 US National Health and Wellness Survey (NHWS)

Shawn G. Kwatra, David Gruben, Selwyn Fung, Marco DiBonaventura
#142 - Eczema Area and Severity Index-90 (EASI-90) Responder Rates With Abrocitinib and Relationship With Quality of Life (QoL) and Itch in Patients With Moderate-to-Severe Atopic Dermatitis (AD): Results From a Randomized, Phase 3 Clinical Trial

Gil Yosipovitch, Thomas Bieber, Linda Stein Gold, Shawn G. Kwatra, Svitlana Tatulych, Chudy Nduaka, Michael C. Cameron, David Williams, Pinaki Biswas, Hernan Valdez
#143 - Multiple Scrotal Cysts Composed of Combined Syringomas and Epidermal Inclusion Cysts: A Previously Unreported Association

My Diep BS, MS and David Cassarino PhD, MD
#144 -  Atypical Mycobacterium Marinum: A Case of Fish Tank Granuloma

Emily Wootton, BS, Christina Borchers, MD, Samia Borchers, MD, Nicholas Shamma, MD,  Bernard Rose, MD, Max Rubin, MD
#145 - Vulvo-vaginal vs. Cutaneous Melanoma: A Retrospective Cohort Study on Cutaneous Immune-Related Adverse Events

Sheida Naderi-Azad, Faisal Sickander, Rossanna Pezo